David Francisco serves as the Chief Financial Officer and Principal Financial Officer at Organogenesis Holdings Inc Class A, a leading regenerative medicine company focused on developing and commercializing advanced wound care and sports medicine products. In his role, Francisco is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, and investor relations. His strategic vision and financial expertise have been instrumental in guiding Organogenesis through its growth and expansion phases. Before joining Organogenesis, Francisco held various senior financial positions at several prominent companies in the healthcare and biotechnology sectors. He has a proven track record of successfully managing complex financial operations and implementing effective cost-saving measures. Francisco's extensive experience in financial management and his deep understanding of the healthcare industry have enabled him to make significant contributions to Organogenesis' financial stability and growth. Under Francisco's leadership, Organogenesis has achieved several notable milestones, including the successful launch of new products and the expansion of its market presence. His ability to navigate the company through challenging economic conditions and his commitment to driving financial performance have earned him a reputation as a highly respected and effective financial leader. Francisco's dedication to the company's mission of improving patient outcomes through innovative regenerative medicine solutions continues to drive Organogenesis forward as a leader in the industry.